Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q3 EBITDA Grows To SEK 5.9 Mln

Oct 27 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * INTERIM REPORT JANUARY - SEPTEMBER 2022
    * Q3 NET SALES AMOUNTED TO SEK 96.8 MILLION (54.9)
    * Q3 EBITDA AMOUNTED TO SEK 5.9 MILLION (4.2)
    * Q3 OPERATING INCOME (EBIT) AMOUNTED TO SEK -4.7 MILLION
(-4.0)

Source text for Eikon:  ID:nMFN54JdjZ 
Further company coverage:  XVIVO.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Xvivo Perfusion AB

See all news